Effect of aqueous extract of Aegle marmelos unripe fruit on inflammatory bowel disease
- PMID: 23112424
- PMCID: PMC3480795
- DOI: 10.4103/0253-7613.100389
Effect of aqueous extract of Aegle marmelos unripe fruit on inflammatory bowel disease
Abstract
Objective: The present study was designed to evaluate the effect of Aegle marmelos unripe fruit extract (AMFE) on inflammatory bowel disease (IBD) in Wistar albino rats.
Materials and methods: Effect of AMFE was studied on acetic acid induced ulcerative colitis (1 ml of 4% acetic acid solution, transrectal) and indomethacin-induced enterocolitis (10 mg/kg, single dose, p.o) in Wistar albino rats. The extract was administered orally at different dose of 150, 200 and 250 mg/kg body weight. Disease pathogenesis was assessed by measuring disease activity index (DAI), macroscopic score, microscopic score, mesenteric mast cell protection, superoxide dismutase (SOD), and malonaldehyde (MDA) levels in the above two models.
Results: The results showed a dose dependent decrease in intestinal inflammation following treatment with AMFE. Significant protection in mast cell degranulation was observed in acetic acid and indomethacin-induced IBD models. Treatment with AMFE significantly decreased the MDA levels and increased SOD activity.
Conclusion: In our study, AMFE produced anti-inflammatory, antioxidant, and mast cell stabilizing effects demonstrating protective effect in inflammatory bowel disease.
Keywords: Aegle marmelos (bael); aqueous extract; inflammatory bowel disease.
Conflict of interest statement
Figures


Similar articles
-
Effect of aqueous extract of Aegle marmelos fruit and leaf on glycemic, insulinemic and lipidemic status of type 2 diabetic model rats.J Complement Integr Med. 2017 Mar 9;14(2):/j/jcim.2017.14.issue-2/jcim-2016-0111/jcim-2016-0111.xml. doi: 10.1515/jcim-2016-0111. J Complement Integr Med. 2017. PMID: 28284036
-
The effect of Aegle marmelos fruit extract in streptozotocin diabetes: a histopathological study.J Herb Pharmacother. 2005;5(3):87-96. J Herb Pharmacother. 2005. PMID: 16520300
-
In vivo and molecular docking studies using whole extract and phytocompounds of Aegle marmelos fruit protective effects against Isoproterenol-induced Myocardial infarction in rats.Biomed Pharmacother. 2017 Jul;91:880-889. doi: 10.1016/j.biopha.2017.04.115. Epub 2017 May 12. Biomed Pharmacother. 2017. PMID: 28511341
-
Bioactive compounds of Aegle marmelos L., medicinal values and its food applications: A critical review.Phytother Res. 2021 Apr;35(4):1887-1907. doi: 10.1002/ptr.6934. Epub 2020 Nov 6. Phytother Res. 2021. PMID: 33159390 Review.
-
Aegle marmelos (L.) Correa: An Underutilized Fruit with High Nutraceutical Values: A Review.Int J Mol Sci. 2022 Sep 17;23(18):10889. doi: 10.3390/ijms231810889. Int J Mol Sci. 2022. PMID: 36142805 Free PMC article. Review.
Cited by
-
Animal models of inflammatory bowel disease: a review.Inflammopharmacology. 2014 Aug;22(4):219-33. doi: 10.1007/s10787-014-0207-y. Epub 2014 Jun 7. Inflammopharmacology. 2014. PMID: 24906689 Review.
-
Enteric-Coated Cologrit Tablet Exhibit Robust Anti-Inflammatory Response in Ulcerative Colitis-like In-Vitro Models by Attuning NFκB-Centric Signaling Axis.Pharmaceuticals (Basel). 2022 Dec 31;16(1):63. doi: 10.3390/ph16010063. Pharmaceuticals (Basel). 2022. PMID: 36678560 Free PMC article.
-
L-Glutamine and Physical Exercise Prevent Intestinal Inflammation and Oxidative Stress Without Improving Gastric Dysmotility in Rats with Ulcerative Colitis.Inflammation. 2021 Apr;44(2):617-632. doi: 10.1007/s10753-020-01361-3. Epub 2020 Oct 31. Inflammation. 2021. PMID: 33128666
-
Protective effect of Agave americana Linn. leaf extract in acetic acid-induced ulcerative colitis in rats.Ayu. 2015 Jan-Mar;36(1):101-6. doi: 10.4103/0974-8520.168998. Ayu. 2015. PMID: 26730148 Free PMC article.
-
GB1a Ameliorates Ulcerative Colitis via Regulation of the NF-κB and Nrf2 Signaling Pathways in an Experimental Model.Front Med (Lausanne). 2021 Sep 7;8:654867. doi: 10.3389/fmed.2021.654867. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34557497 Free PMC article.
References
-
- Sellin JH, Pasricha PJ. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 11th ed. NewYork: McGraw-Hill Publications; 2006. Pharmacotherapy of inflammatory bowel disease; p. 1009.
-
- Bickson SJ. Treatment of chronic disease at the turn of the century. N Engl J Med. 1998;339:401–2. - PubMed
-
- Hana Strul MD, Nadir Arber MD. Inflammatory bowel disease, ulcerative colitis, Crohn's disease, pathophysiology, new therapies. IMAJ. 2000;2:607–9. - PubMed
-
- Parkes M, Jewell D. Ulcerative Colitis and Crohn's disease: Molecular genetics and clinical implications. Expert Rev Mol Med. 2001;2001:1. 1800391-Xa.pdf. - PubMed
-
- Calkins BM, Mendeloff AI. The epidemiology of idiopathic inflammatory bowel disease. In: Kirsner JB, Shorter RG, editors. Inflammatory Bowel Disease. 4th ed. Baltimore: Williams and wilkins; 1995. pp. 31–68.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources